EPI-ENDO: Randomized Comparison of Endocardial Versus Epicardial - From the Coronary Sinus - Left Ventricular Pacing for Resynchronization in Heart Failure.

Sponsor
University Hospital, Bordeaux (Other)
Overall Status
Completed
CT.gov ID
NCT01260402
Collaborator
(none)
6
1
2
52.9
0.1

Study Details

Study Description

Brief Summary

Biventricular pacing is a validated treatment for patients suffering from heart failure resistant to medical treatment. However, up to 30% of the patients are non responsive to this strategy using the coronary sinus approach to pace the Left Ventricle (LV).

It has been demonstrated that the magnitude of the improvement was highly dependant on the LV pacing site. The coronary sinus approach rarely offers more than 1 or 2 potential pacing sites. Resynchronisation using a transeptal approach to pace the left ventricle on the cardiology has been shown feasible on small series. We therefore would like to compare these two approached in a randomised prospective study to confirm the hypotheses that endocardial LV pacing by offering multiple choices for the pacing sites reduces the number of non responders and is associated with greater hemodynamic benefit when compared to the conventional coronary sinus approach.

Condition or Disease Intervention/Treatment Phase
  • Device: Resynchronization using a transeptal approach
  • Device: Resynchronization using a coronary sinus approach
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
6 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Randomized Comparison of Endocardial Versus Epicardial - From the Coronary Sinus - Left Ventricular Pacing for Resynchronization in Heart Failure.
Actual Study Start Date :
Mar 3, 2011
Actual Primary Completion Date :
Jan 1, 2015
Actual Study Completion Date :
Jul 30, 2015

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Epicardial

Device: Resynchronization using a coronary sinus approach
Cardiac resynchronization with one in the right ventricle and one in the left ventricle via the coronary sinus. Devices used for procedure : RADI PressureWire, routine catheters chosen by operator

Experimental: Endocardial

Device: Resynchronization using a transeptal approach
Cardiac resynchronization with one in the right ventricle and one in the left ventricle via a transeptal puncture. Devices used for procedure : Medtronic C304 or 6227DEF, Nykanen RF Wire, RADI PressureWire

Outcome Measures

Primary Outcome Measures

  1. the acute hemodynamic response judged by dP/dt max [Visit 3 : implantation day, during pacing procedure]

    The primary outcome will be the acute hemodynamic response of the randomized pacing modality (endocardial vs epicardial Left Ventricle pacing) as judged by the highest gain in dP/dt max

Secondary Outcome Measures

  1. Implant success rate [Visit 3 : implantation day, end of pacing procedure]

  2. number of left ventricular pacing sites assessed [Visit 3 : implantation day, end of pacing procedure]

  3. Pacing Procedure duration [Visit 3 : implantation day, end of pacing procedure]

  4. Per and post implantation complications rate [Visit 4 : within 7 days after pacing procedure]

  5. Post implantation echocardiography comparing spontaneous rhythm and biventricular pacing for left ventricle ejection fraction [within 7 days after pacing procedure]

  6. Post implantation echocardiography comparing spontaneous rhythm and biventricular pacing for mitral regurgitation [within 7 days after pacing procedure]

  7. Post implantation echocardiography comparing spontaneous rhythm and biventricular pacing for atrioventricular asynchronism [within 7 days after pacing procedure]

  8. Post implantation echocardiography comparing spontaneous rhythm and biventricular pacing for inter and intra-ventricular asynchronism [within 7 days after pacing procedure]

  9. sensing performances of left ventricle pacing leads [within 7 days after pacing procedure]

  10. pacing threshold performances of left ventricle pacing leads [within 7 days after pacing procedure]

  11. impedances performances of left ventricle pacing leads [within 7 days after pacing procedure]

  12. Complications rate at 6 month Follow up [Visit 6 : 6-months after pacing procedure]

  13. Clinical benefit at 6 month Follow up: Gain in NYHA [6-months after pacing procedure]

  14. Clinical benefit at 6 month Follow up: 6 minutes walk test [6-months after pacing procedure]

  15. Clinical benefit at 6 month Follow up: quality of life questionnaire as compared to pre implantation [6-months after pacing procedure]

  16. Echocardiography at 6 month Follow up: as compared to pre implantation for Left Ventricular Ejection Fraction [6-months after pacing procedure]

  17. Echocardiography at 6 month Follow up: as compared to pre implantation for Left Ventricle volumes [6-months after pacing procedure]

  18. Echocardiography at 6 month Follow up: as compared to pre implantation for mitral regurgitation [6-months after pacing procedure]

  19. Echocardiography at 6 month Follow up: as compared to pre implantation for atrioventricular asynchronism [6-months after pacing procedure]

  20. Echocardiography at 6 month Follow up: as compared to pre implantation for inter and intra-ventricular asynchronism [6-months after pacing procedure]

  21. sensing performances of Left Ventricle pacing leads at 6 month Follow up [6-months after pacing procedure]

  22. pacing threshold performances of Left Ventricle pacing leads at 6 month Follow up [6-months after pacing procedure]

  23. impedances performances of Left Ventricle pacing leads at 6 month Follow up [6-months after pacing procedure]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adult (aged 18 or above)

  • Cardiac insufficiency of whatever cause (ischemic or non-ischemic)

  • Left ventricular ejection fraction <35%

  • NYHA Class III or IV with optimal medical treatment

  • QRS duration > 120 ms

  • Sinus rhythm

  • Patient must have signed informed consent

  • Patient must be registered in the national health care system

Exclusion Criteria:
  • Aged under 18

  • Patient with a mitral or aortic prosthesis

  • Patient with contraindication to anti-coagulants

  • Pregnant women

  • Participation in another study

  • Patient with contraindication for left ventricle catheterization by retrograde aortic approach , as a severe aortic stenosis requiring surgery, or an ascending aorta aneurism

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cardiologic Hospital Haut l'évêque Pessac France 33604

Sponsors and Collaborators

  • University Hospital, Bordeaux

Investigators

  • Principal Investigator: Pierre JAIS, MD, University Hospital Bordeaux, France

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Bordeaux
ClinicalTrials.gov Identifier:
NCT01260402
Other Study ID Numbers:
  • CHUBX 2010/12
First Posted:
Dec 15, 2010
Last Update Posted:
Feb 25, 2022
Last Verified:
Feb 1, 2022

Study Results

No Results Posted as of Feb 25, 2022